Literature DB >> 22590280

4,5-Dibromo-1,2-dimethyl-1H-imidazol-3-ium bromide.

Mebarek Bahnous, Abdelmalek Bouraiou, Sofiane Bouacida, Thierry Roisnel, Ali Belfaitah.   

Abstract

In the title salt, C(5)H(7)Br(2)N(2) (+)·Br(-), the cation and anion are connected by an N-H⋯Br hydrogen bond. In the crystal, there are inter-calated layers parallel to (10-2) in which bromide ions are located between the cations. Weak inter-molecular C-H⋯Br hydrogen bonds are also observed.

Entities:  

Year:  2012        PMID: 22590280      PMCID: PMC3344518          DOI: 10.1107/S1600536812015310

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the preparation of the title compound using the Ortoleva–King reaction, see: King (1944 ▶). For applications of C,N-substituted haloimidazole derivatives, see: Reepmeyer et al. (1975 ▶); Zamora et al. (2003 ▶); Schmidt & Schieffer (2003 ▶); Mashkovskii (2005 ▶); Amini et al. (2007 ▶).

Experimental

Crystal data

C5H7Br2N2Br M = 334.86 Monoclinic, a = 5.5938 (3) Å b = 11.2522 (6) Å c = 14.4864 (9) Å β = 104.571 (3)° V = 882.48 (9) Å3 Z = 4 Mo Kα radiation μ = 13.64 mm−1 T = 150 K 0.31 × 0.22 × 0.17 mm

Data collection

Bruker APEXII diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2002 ▶) T min = 0.058, T max = 0.098 7565 measured reflections 2032 independent reflections 1747 reflections with I > 2σ(I) R int = 0.050

Refinement

R[F 2 > 2σ(F 2)] = 0.027 wR(F 2) = 0.060 S = 1.03 2032 reflections 94 parameters H-atom parameters constrained Δρmax = 0.63 e Å−3 Δρmin = −0.86 e Å−3 Data collection: APEX2 (Bruker, 2004 ▶); cell refinement: SAINT (Bruker, 2004 ▶); data reduction: SAINT; program(s) used to solve structure: SIR2002 (Burla et al., 2005 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶) and DIAMOND (Brandenburg & Berndt, 2001 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536812015310/lh5448sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812015310/lh5448Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536812015310/lh5448Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C5H7Br2N2+·BrF(000) = 624
Mr = 334.86Dx = 2.52 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 3086 reflections
a = 5.5938 (3) Åθ = 2.9–27.5°
b = 11.2522 (6) ŵ = 13.64 mm1
c = 14.4864 (9) ÅT = 150 K
β = 104.571 (3)°Prism, colourless
V = 882.48 (9) Å30.31 × 0.22 × 0.17 mm
Z = 4
Bruker APEXII diffractometer1747 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.050
CCD rotation images, thin slices scansθmax = 27.5°, θmin = 3.4°
Absorption correction: multi-scan (SADABS; Bruker, 2002)h = −6→7
Tmin = 0.058, Tmax = 0.098k = −14→12
7565 measured reflectionsl = −18→17
2032 independent reflections
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.027H-atom parameters constrained
wR(F2) = 0.060w = 1/[σ2(Fo2) + (0.0201P)2 + 0.142P] where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max = 0.002
2032 reflectionsΔρmax = 0.63 e Å3
94 parametersΔρmin = −0.86 e Å3
0 restraintsExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.0075 (4)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br10.52217 (6)0.60967 (3)0.40218 (2)0.01621 (11)
Br20.12689 (6)0.86245 (3)0.44145 (2)0.01726 (11)
N20.7783 (5)0.7167 (2)0.57813 (19)0.0142 (6)
N50.5520 (5)0.8641 (3)0.5998 (2)0.0171 (6)
H50.49870.92660.62510.021*
C10.7626 (6)0.8069 (3)0.6365 (2)0.0163 (7)
C30.5709 (6)0.7178 (3)0.5019 (2)0.0141 (7)
C40.4301 (6)0.8096 (3)0.5154 (2)0.0140 (7)
C60.9445 (7)0.8397 (3)0.7253 (2)0.0222 (8)
H6A0.98790.77060.76470.033*
H6B0.87450.89860.75870.033*
H6C1.08960.87130.71030.033*
C70.9765 (7)0.6294 (3)0.5945 (3)0.0214 (8)
H7A1.10620.65310.64830.032*
H7B1.04030.62420.53900.032*
H7C0.91370.55320.60690.032*
Br30.58756 (6)0.58078 (3)0.77871 (2)0.01713 (12)
U11U22U33U12U13U23
Br10.0170 (2)0.01589 (19)0.01515 (19)0.00097 (14)0.00295 (14)−0.00101 (12)
Br20.01324 (19)0.0185 (2)0.01989 (19)0.00293 (14)0.00389 (14)0.00221 (13)
N20.0086 (14)0.0175 (15)0.0156 (14)−0.0021 (12)0.0013 (11)0.0037 (11)
N50.0193 (16)0.0141 (15)0.0185 (15)−0.0040 (12)0.0060 (12)−0.0026 (11)
C10.0153 (18)0.0171 (18)0.0162 (17)−0.0055 (14)0.0031 (14)0.0020 (14)
C30.0124 (17)0.0172 (17)0.0123 (16)−0.0017 (14)0.0022 (13)0.0011 (13)
C40.0107 (17)0.0173 (18)0.0138 (16)−0.0015 (14)0.0029 (13)−0.0020 (13)
C60.021 (2)0.025 (2)0.0182 (18)−0.0087 (16)0.0008 (15)−0.0019 (15)
C70.0156 (19)0.023 (2)0.024 (2)0.0058 (15)0.0019 (16)0.0075 (14)
Br30.0163 (2)0.0161 (2)0.01874 (19)−0.00155 (13)0.00405 (14)−0.00052 (13)
Br1—C31.855 (3)C1—C61.472 (5)
Br2—C41.861 (3)C3—C41.343 (5)
N2—C11.338 (4)C6—H6A0.9600
N2—C31.386 (4)C6—H6B0.9600
N2—C71.456 (4)C6—H6C0.9600
N5—C11.329 (4)C7—H7A0.9600
N5—C41.385 (4)C7—H7B0.9600
N5—H50.8800C7—H7C0.9600
C1—N2—C3108.8 (3)N5—C4—Br2122.8 (2)
C1—N2—C7125.3 (3)C1—C6—H6A109.5
C3—N2—C7125.9 (3)C1—C6—H6B109.5
C1—N5—C4109.2 (3)H6A—C6—H6B109.5
C1—N5—H5125.4C1—C6—H6C109.5
C4—N5—H5125.4H6A—C6—H6C109.5
N5—C1—N2107.9 (3)H6B—C6—H6C109.5
N5—C1—C6125.2 (3)N2—C7—H7A109.5
N2—C1—C6127.0 (3)N2—C7—H7B109.5
C4—C3—N2107.1 (3)H7A—C7—H7B109.5
C4—C3—Br1129.9 (2)N2—C7—H7C109.5
N2—C3—Br1123.0 (2)H7A—C7—H7C109.5
C3—C4—N5107.0 (3)H7B—C7—H7C109.5
C3—C4—Br2130.2 (2)
C4—N5—C1—N2−0.3 (4)C1—N2—C3—Br1178.4 (2)
C4—N5—C1—C6179.1 (3)C7—N2—C3—Br1−3.8 (5)
C3—N2—C1—N50.4 (4)N2—C3—C4—N50.0 (4)
C7—N2—C1—N5−177.4 (3)Br1—C3—C4—N5−178.5 (2)
C3—N2—C1—C6−179.0 (3)N2—C3—C4—Br2−179.7 (2)
C7—N2—C1—C63.2 (5)Br1—C3—C4—Br21.7 (5)
C1—N2—C3—C4−0.2 (4)C1—N5—C4—C30.2 (4)
C7—N2—C3—C4177.5 (3)C1—N5—C4—Br2180.0 (2)
D—H···AD—HH···AD···AD—H···A
N5—H5···Br3i0.882.353.216 (3)168
C6—H6A···Br2ii0.962.903.796 (3)156
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N5—H5⋯Br3i0.882.353.216 (3)168
C6—H6A⋯Br2ii0.962.903.796 (3)156

Symmetry codes: (i) ; (ii) .

  3 in total

Review 1.  Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.

Authors:  Boris Schmidt; Bernhard Schieffer
Journal:  J Med Chem       Date:  2003-06-05       Impact factor: 7.446

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9.

Authors:  Ismael Zamora; Lovisa Afzelius; Gabriele Cruciani
Journal:  J Med Chem       Date:  2003-06-05       Impact factor: 7.446

  3 in total
  6 in total

1.  Methyl 2-(2-methyl-4-nitro-1H-imidazol-1-yl)acetate.

Authors:  Sana Zama; Abdelmalek Bouraiou; Sofiane Bouacida; Thierry Roisnel; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-04

2.  3-Anilino-5,5-di-methyl-cyclo-hex-2-enone.

Authors:  Houssem Boulebd; Abdelmalek Bouraiou; Sofiane Bouacida; Hocine Merazig; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-02-05

3.  Crystal structure of 1-[(1-methyl-5-nitro-1H-imidazol-2-yl)meth-yl]pyridinium iodide.

Authors:  Roumaissa Belguedj; Abdelmalek Bouraiou; Hocine Merazig; Ali Belfaitah; Sofiane Bouacida
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-28

4.  2-Hy-droxy-methyl-1,3-dimethyl-1H-imidazol-3-ium triiodide.

Authors:  Mohamed El Hadi Said; Abdelmalek Bouraiou; Sofiane Bouacida; Hocine Merazig; Ali Belfaitah; Aissa Chibani
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-27

5.  2-Hy-droxy-methyl-1,3-dimethyl-1H-benzimidazol-3-ium iodide.

Authors:  Mohamed El Hadi Said; Sofiane Bouacida; Hocine Merazig; Ali Belfaitah; Aissa Chibani; Abdelmalek Bouraiou
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-08-14

6.  Crystal structure of (E)-1-methyl-2-[2-(2-methoxphen-yl)ethen-yl]-4-nitro-1H-imidazole.

Authors:  Hayette Alliouche; Abdelmalek Bouraiou; Sofiane Bouacida; Hocine Merazig; Ali Belfaitah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.